The prevalence of multiple sclerosis in Belo Horizonte, Brazil;Prevalência da esclerose múltipla em Belo Horizonte, Brasil

Arquivos de Neuro-Psiquiatria

Volumn 70, Issue 2, 2012, Pages 102-107

  Lana Peixoto, Marco A ^a   Frota, Elizabeth R C ^a   Campos, Gilberto B ^a   Monteiro, Leonardo P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Belo horizonte; Multiple sclerosis; Prevalence; Southeastern brazil

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAZIL; CHILD; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; INFANT; MALE; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 84857137440     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2012000200006     Document Type: Article

References (34)

1. Compston A, Wekerle H. The genetics of multiple sclerosis. In: Compston A, Canfavreux C, McDonald I, et al. (Eds). McAlpine's Multiple Sclerosis. 4th edition. Philadelphia: Churchill Livingstone Elsevier; 2006. p. 113-182.
2. Compston A, Confavreux C. The distribution of multiple sclerosis. In: Compston A, Canfavreux C, McDonald I, et al. (Eds). McAlpine's Multiple Sclerosis. 4th edition. Philadelphia: Churchill Livingstone Elsevier; 2006. p. 71-105.
3. Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiology 2007;29:150-155.
4. Cristiano E, Patrucco L, Garcea O, et al. Prevalence of multiple sclerosis in Buenos Aires, Argentina, using the capture-recapture method. Eur J Neurol 2009;16:183-187.
5. Sánchez JL, Aguirre C, Arcos-Burgos OM, et al. Prevalencia de la esclerosis múltiple en Colombia. Rev Neurol 2000;31:1101-1103.
6. Velásquez MM, López Prieto, Marquez JC, Riviera CM, Vargas ML. Características epidemiológicas de la esclerosis múltiple en un estado fronteirizo con los Estados Unidos de Norteamérica. Arch Neuroscien Mex 2002;7:147-150.
7. Ketzoian C, Oehninger C, Alcántara J, et al. Estudio de la prevalencia de la esclerosis múltiple en el Uruguay. Acta Neurol Colomb 1999;15 (Suppl):S6.
8. Cristiano E, Patrucco L, Rojas JI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol 2008;15:1273-1278.
9. Arruda WO, Scola RH, Teive HA, Werneck LC. Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series. Arq Neuropsiquiatr 2001;59:165-170.
10. Ferreira ML, Machado MI, Vilela ML, et al. Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauração, Recife, Pernambuco, Brazil. Arq Neuropsiquiatr 2004,62:1027-1032.
11. Fragoso YD, Fiore AP. Description and characteristics of 81 patients attending the Reference Center for Multiple Sclerosis of the coastal region of the state of São Paulo-Brazil. Arq Neuropsiquiatr 2005;63:741-744.
12. Grzesiuk AK. Clinical and epidemiologic characteristics of 20 patients with multiple sclerosis in Cuiabá-Mato Grosso, Brazil. Arq Neuropsiquiatr 2006;64:635-638.
13. Santos EC, Yokota M, Dias NF. Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary of State for Health. Arq Neuropsiquiatr 2007;65:885-888.
14. Finkelsztejn A, Cristovam Rdo A, Moraes GS, et al. Clinical features of multiple sclerosis in the south of Brazil: a partial analysis. Arq Neuropsiquiatr 2009;67:1071-1075.
15. Kaimen-Maciel DR, Medeiros M, Pisori R, Biaggio C, Rocha F, Lopes LHG. The prevalence of multiple sclerosis in two cities in north of Paraná State, Brazil. Mult Scler 2004;10 (Suppl):S158.
16. Gama PD, Trigo LX, Andrade CRR, Sala CR. Epidemiological study of multiple sclerosis in the city of Sorocaba, Brazil. Arq Neuropsiquiatr 2004;62 (Suppl):S13.
17. Alves-Leon SV, Papais-Alvarenga R, Magalhães M, Alvarenga M, Thuler LC, Fernández y Fernandez O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand 2007;115:306-311.
18. Brum DG, Barreira AA, Louzada-Junior P, Mendes-Junior CT, Donadi EA. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1 *1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil. J Neuroimmunol 2007;189:118-124.
19. Ferreira Vasconcelos CC, Santos Thuler LC, Cruz dos Santos GA, et al. Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients. Mult Scler 2010;16:597-603.
20. Negreiros MA, Mattos P, Landeira-Fernandez J, Paes RA, Alvarenga RP. A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients. Brain Inj 2008,22:419-426.
21. Haase VG, Lima Ede P, Lacerda SS, Lana-Peixoto MA. Development of the Brazilian version of the Multiple Sclerosis Functional Composite Measure (MSFC-BCTRIMS): pilot study. Arq Neuropsiquiatr 2004;62:363-369.
22. Fragoso YD, Finkelsztejn A, Giacomo MC, Russo L, Cruz WS. The effect of multiple sclerosis on the professional life of a group of Brazilian patients. Arq Neuropsiquiatr 2010;68:914-917.
23. Callegaro D, Lolio CA, Radvany J, Tilbery CP, Mendonça RA, Melo AC. Prevalence of multiple sclerosis in the city of São Paulo, Brazil, in 1990. Neuroepidemiology 1992;11:11-14.
24. Callegaro D, Goldbaum M, Tilbery CP, et al. The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997. Acta Neurol Scand 2001;104:208-213.
25. Rocha FC, Herrera LC, Morales RR and The Brazilian Committee for Treatment and Research in Multiple Sclerosis. Multiple sclerosis in Botucatu, Brazil. A population study. Mult Scler 2002;8(Suppl):S41-S42.
26. Instituto Brasileiro de Geografia e Estatística (IBGE). Available from: www.ibge.gov.br.
27. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
28. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
29. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
30. Christensen JC. Multiple sclerosis: some epidemiological clues to its etiology. Acta Neurol Latinoam 1975;21:66-85.
31. Alter M, Olivares L. Multiple sclerosis in Mexico. An epidemiologic study. Arch Neurol 1970;23:451-459.
32. Toro J, Sarmiento OI, Díaz del Castillo A, et al. Prevalence of multiple sclerosis in Bogotá, Colombia. Neuroepidemiology 2007;28:33-38.
33. Sánchez JL, Palacio LG, Uribe CS, et al. Clinical features of multiple sclerosis in a genetically homogenous tropical population. Mult Scler 2001;4:227-229.
34. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988;111:1-25.